Navigation Links
Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia
Date:12/8/2009

> All patients had a minimum of 12 months of treatment or discontinued early; the median follow-up was 14 months. Overall, 84%, 82% and 79% of patients remained in the study on nilotinib 300mg twice-daily, nilotinib 400mg twice-daily and imatinib 400mg once-daily, respectively.(1)

About Ph+ CML

CML is a disease in which the body produces cancerous (leukaemic) white blood cells. 95% of patients with CML have an abnormality known as the Philadelphia chromosome. This chromosome produces a protein called Bcr-Abl, which is responsible for the proliferation of leukaemic white blood cells in Ph+ CML.(3)

CML accounts for more than one in six leukaemias in adults, with around 600 new cases being registered in England and Wales each year.(2) The estimated prevalence of CML in 2003 in England and Wales was 2,660 patients.(2)

About Tasigna (nilotinib)

Nilotinib, a second generation TKI, is a potent and selective inhibitor of the Bcr-Abl protein, which is responsible for the proliferation of leukaemic white blood cells in Ph+ CML.(4,5) Nilotinib is indicated for the treatment of adults with chronic phase and accelerated phase Ph+ CML with resistance or intolerance to prior therapy including imatinib. Efficacy data in patients with CML in blast crisis are not available.(5)

For nilotinib summary of product characteristics, please see: http://emc.medicines.org.uk/medicine/20827/SPC/ Tasigna%20200%20mg%20hard%20capsules

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

About Glivec (imatinib)(7)

Imatinib is approved in the EU for the treatment of all phases of Ph+ CML. Imatinib is also indicated for the treatment of adult patients with Kit (CD 117)
'/>"/>

SOURCE Novartis Oncology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... BETHESDA, Md. , March 3, 2015 /PRNewswire/-- ViaCyte, ... stem cell-derived islet replacement therapy for the treatment of ... Dr. Eugene Brandon , Director of Strategic Relations ... annual summit showcases the latest in type 1 diabetes ... presentation are as follows: , , , ...
(Date:3/3/2015)... SHANGHAI , March 3, 2015 ... 24 - 26 June 2015, SNIEC, Shanghai, China ... with the 10th P-MEC China, will be held at Shanghai ... CPhI & P-MEC China originated from CPhI Worldwide and was ... become an important bridge between Chinese pharmaceutical companies and global ...
(Date:3/3/2015)... - ChipCare Corporation, a University of Toronto start-up company ... other infectious and non-communicable diseases has closed a ... first-generation product to market while further developing the ... http://photos.prnewswire.com/prnh/20150303/179107 ) Insufficient access ... affordable diagnostic tests makes it difficult to provide ...
Breaking Medicine Technology:ViaCyte to Present at JDRF TypeOneNation Research Summit 215th Anniversary, Be Part of Chinese Pharma Dream 215th Anniversary, Be Part of Chinese Pharma Dream 3ChipCare Closes Oversubscribed $5 Million Series A Financing 2ChipCare Closes Oversubscribed $5 Million Series A Financing 3
(Date:3/4/2015)... March 04, 2015 Nurses, healthcare professionals ... American Cannabis Nurses Association (ACNA) to learn about why ... wide array of illnesses and conditions. The one-day continuing ... is being offered on April 1 or April 2 ... was approved by the Ohio Nurses Association (OBN-001-91), an ...
(Date:3/3/2015)... Anik Singal's Profit Academy - a ... has become the talk of the town throughout ... the course's general release has garnered the attention ... to review the program's content and publish an ... keys to success with Internet marketing is having ...
(Date:3/3/2015)... New York (PRWEB) March 03, 2015 ... tactics used to market the atypical antipsychotic medication ... U.S. According to court documents, the South Carolina ... finding that Johnson & Johnson’s Janssen Pharmaceuticals unit ... serious risks. However, while the Court’s February 25th ...
(Date:3/3/2015)... Longtime parent visionary and inspiring new ... Center for a candid interview on the surrogacy ... an exhilarating revelation of his magical surrogacy journey — ... Australia to the birth of his precious twin girls. ... CEO and Founder of CARE stated, “We are committed ...
(Date:3/3/2015)... 03, 2015 Man, Woman & Student ... help find cures and ensure access to treatments for ... for patents and their families. Through this annual national ... the fight for a world without blood cancers. The ... in the country, to be announced this summer. To ...
Breaking Medicine News(10 mins):Health News:American Cannabis Nurses Association Announces Speaker Lineup for Educational Seminar in Cleveland 2Health News:American Cannabis Nurses Association Announces Speaker Lineup for Educational Seminar in Cleveland 3Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 3Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 3
... offer tips to avoid mowing-related hazards , SATURDAY, ... such a common summertime activity that many people forget ... warn. , Each year in the United States, about ... mower-related accidents, according to the U.S. Consumer Product Safety ...
... Nearly 600 Kidney-Friendly Recipes to Meet Kidney Care Needs for ... DaVita Inc. (NYSE: DVA ), a leading provider ... disease (CKD), offers fathers and their families the opportunity to ... nearly 600 kidney-friendly recipes available on DaVita.com ...
... visit Healthy Athletes Village and hand out awards , ... to catch Summer Games action at the University of ... Village today from 9:30-10 a.m. and will hand out awards ... Field. , , Healthy Athletes is an initiative designed ...
... D.C. The amount of time imaging equipment is ... rates President Obama and the Medicare Payment Advisory Commission ... according to data recently collected by the Radiology Business ... in radiology. The RBMA data, which consist ...
... -- Cell Therapeutics, Inc. (the "Company" or "CTI") (Nasdaq ... separate concurrent fixed price exchange offers (each, an "Exchange Offer" ... the approximately $118.9 million outstanding principal amount of five series ... expired at 5:00 p.m., New York City time, on Tuesday, ...
... Boston, MA -- As President Obama prepares to sign ... oversight of the tobacco industry, a new study from ... tobacco manufacturers have continually changed the ingredients and the ... changes have exceeded acceptable product variance guidelines. The result, ...
Cached Medicine News:Health News:Don't Get Lazy About Lawn-Mower Safety 2Health News:DaVita.com Provides Easy Recipes to Plan Your Father's Day Dinner 2Health News:DaVita.com Provides Easy Recipes to Plan Your Father's Day Dinner 3Health News:Last Day of Special Olympics Minnesota's 2009 Summer Games 2Health News:Last Day of Special Olympics Minnesota's 2009 Summer Games 3Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 2Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 3Health News:Data: Actual imaging use far below president's recommended 95 percent utilization rate for Medicare 4Health News:Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 2Health News:Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 3Health News:Study finds that tobacco companies changed design of cigarettes without alerting smokers 2
... fiberoptic laryngoscope blade that can give that ... during difficult intubations. The articulating tip design ... be raised by squeezing a lever next ... a more complete exposure of the glottis, ...
... The FR-120F, Fujinon's new fiberoptic Naso-Pharyngo-Laryngoscope ... and patient comfort. The latest in ... an increased light guide, and a wide ... very impressive 3.3mm distal tip diameter. ...
... Articulating Tip Laryngoscopes are the ... Industry. The articulating tip aids ... an improved view of epiglottis. ... Optic styles. We guarantee your ...
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
Medicine Products: